• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症管理的综合方法:应对隐匿症状——一项叙述性综述

Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.

作者信息

Lakin Lynsey, Davis Bryan E, Binns Cherie C, Currie Keisha M, Rensel Mary R

机构信息

The Neurology Group, 9120 Haven Ave, Rancho Cucamonga, CA, USA.

Comprehensive MS Center, The University of California Riverside, 3390 University Ave, Suite 100, Riverside, CA, USA.

出版信息

Neurol Ther. 2021 Jun;10(1):75-98. doi: 10.1007/s40120-021-00239-2. Epub 2021 Apr 20.

DOI:10.1007/s40120-021-00239-2
PMID:33877583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8057008/
Abstract

Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system, leading to neurodegeneration and manifesting as a variety of symptoms. These can include "invisible" symptoms, not externally evident to others, such as fatigue, mood disorders, cognitive impairments, pain, bladder/bowel dysfunction, sexual dysfunction, and vision changes. Invisible symptoms are highly prevalent in people living with MS, with multifactorial etiology and potential to impact the disease course. Patient experiences of these symptoms include both physical and psychosocial elements, which when unaddressed negatively influence many aspects of quality of life and perception of health. Despite the high impact on patient lives, gaps persist in awareness and management of these hidden symptoms. The healthcare provider and patient author experiences brought together here serve to raise the profile of invisible symptoms and review strategies for a team-based approach to comprehensive MS care. We summarize the current literature regarding the prevalence and etiology of invisible symptoms to convey the high likelihood that a person living with MS will contend with one or more of these concerns. We then explore how open communication between people living with MS and their care team, stigma mitigation, and shared decision-making are key to comprehensive management of invisible symptoms. We recommend validated screening tools and technological advancements that may be incorporated into MS care to regularly monitor these symptoms, offering insight into how healthcare providers can both educate and listen to patients, with the goal of improved patient quality of life. By pairing clinical knowledge with an understanding and consideration of the patient perspective, providers will be equipped to foster a patient-centered dialogue that encourages shared decision-making. Invisible symptoms of MS.

摘要

多发性硬化症(MS)是一种中枢神经系统的慢性自身免疫性炎症性疾病,会导致神经退行性变,并表现为多种症状。这些症状可能包括他人从外部无法明显察觉的“隐匿性”症状,如疲劳、情绪障碍、认知障碍、疼痛、膀胱/肠道功能障碍、性功能障碍和视力变化。隐匿性症状在多发性硬化症患者中非常普遍,其病因是多因素的,并且有可能影响疾病进程。患者对这些症状的体验包括身体和心理社会因素,若这些因素得不到解决,会对生活质量和健康认知的许多方面产生负面影响。尽管对患者生活影响重大,但在这些隐匿性症状的认知和管理方面仍存在差距。本文汇集了医疗服务提供者和患者作者的经验,旨在提高隐匿性症状的关注度,并审视基于团队的综合多发性硬化症护理策略。我们总结了关于隐匿性症状患病率和病因的现有文献,以表明多发性硬化症患者很可能会面临这些问题中的一个或多个。然后,我们探讨多发性硬化症患者与其护理团队之间的开放沟通、消除污名化以及共同决策如何成为隐匿性症状综合管理的关键。我们推荐可纳入多发性硬化症护理以定期监测这些症状的经过验证的筛查工具和技术进步,深入了解医疗服务提供者如何既能教育患者又能倾听患者意见,以提高患者生活质量。通过将临床知识与对患者观点的理解和考虑相结合,医疗服务提供者将有能力促进以患者为中心的对话,鼓励共同决策。多发性硬化症的隐匿性症状。

相似文献

1
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.多发性硬化症管理的综合方法:应对隐匿症状——一项叙述性综述
Neurol Ther. 2021 Jun;10(1):75-98. doi: 10.1007/s40120-021-00239-2. Epub 2021 Apr 20.
2
What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.认知障碍对多发性硬化症患者的真正影响是什么?对2020年欧洲夏科基金会研讨会讨论的评论
Neurol Ther. 2023 Oct;12(5):1419-1429. doi: 10.1007/s40120-023-00519-z. Epub 2023 Jul 19.
3
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review.患者与医护人员对多发性硬化症对心理健康影响的见解:一项叙述性综述。
Neurol Ther. 2021 Jun;10(1):99-119. doi: 10.1007/s40120-021-00240-9. Epub 2021 Apr 20.
4
A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.对所有医疗环境中共同决策的内部和外部影响进行的定性系统评价。
JBI Libr Syst Rev. 2012;10(58):4633-4646. doi: 10.11124/jbisrir-2012-432.
5
Shared decision-making in multiple sclerosis physical symptomatic care: a systematic review.多发性硬化症身体症状护理中的共同决策:一项系统综述。
Ther Adv Chronic Dis. 2023 Jun 6;14:20406223231172920. doi: 10.1177/20406223231172920. eCollection 2023.
6
The notion of "invisibility" in people's experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis.多发性硬化症症状体验中的“不可见性”概念:系统元综合分析。
Disabil Rehabil. 2021 Nov;43(23):3276-3290. doi: 10.1080/09638288.2020.1741698. Epub 2020 Mar 24.
7
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.多发性硬化症未满足的需求、治疗负担和患者参与:21 世纪多发性硬化症指导小组的综合观点。
Mult Scler Relat Disord. 2018 Jan;19:153-160. doi: 10.1016/j.msard.2017.11.013. Epub 2017 Nov 21.
8
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.医院环境中患者与护士以患者为中心的沟通体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Living with multiple sclerosis: A Jordanian perspective.从约旦视角看多发性硬化症患者的生活
Physiother Res Int. 2018 Apr;23(2):e1709. doi: 10.1002/pri.1709. Epub 2018 Mar 9.

引用本文的文献

1
Qualitative insights from an online community-based exercise intervention for persons living with HIV.一项针对艾滋病毒感染者的基于在线社区的运动干预的定性见解。
Front Rehabil Sci. 2025 Aug 25;6:1602007. doi: 10.3389/fresc.2025.1602007. eCollection 2025.
2
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study.基于芬兰登记处的多发性硬化症疲劳和认知问题筛查与管理方案:观察性研究
JMIR Hum Factors. 2025 Aug 22;12:e67990. doi: 10.2196/67990.
3
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis.

本文引用的文献

1
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review.患者与医护人员对多发性硬化症对心理健康影响的见解:一项叙述性综述。
Neurol Ther. 2021 Jun;10(1):99-119. doi: 10.1007/s40120-021-00240-9. Epub 2021 Apr 20.
2
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.多发性硬化症的认知障碍:临床管理、MRI 和治疗途径。
Lancet Neurol. 2020 Oct;19(10):860-871. doi: 10.1016/S1474-4422(20)30277-5. Epub 2020 Sep 16.
3
The Changes in H-MRS Metabolites in Cuprizone-Induced Model of Multiple Sclerosis: Effects of Prior Psychological Stress.
复发缓解型多发性硬化早期的威胁性疾病认知及相关因素
Front Psychiatry. 2025 Jul 8;16:1565150. doi: 10.3389/fpsyt.2025.1565150. eCollection 2025.
4
Progressive multiple sclerosis: Evaluating current therapies and exploring future treatment strategies.进展性多发性硬化症:评估当前疗法并探索未来治疗策略。
Neurotherapeutics. 2025 Jul;22(4):e00601. doi: 10.1016/j.neurot.2025.e00601. Epub 2025 May 9.
5
Support needs and preferences for people with multiple sclerosis: a rapid review protocol.多发性硬化症患者的支持需求与偏好:一项快速综述方案
BMJ Open. 2025 Apr 22;15(4):e082797. doi: 10.1136/bmjopen-2023-082797.
6
Frequency of tremor in people with multiple sclerosis: A systematic review and meta-analysis.多发性硬化症患者震颤的发生率:一项系统评价和荟萃分析。
Clin Park Relat Disord. 2025 Mar 14;12:100315. doi: 10.1016/j.prdoa.2025.100315. eCollection 2025.
7
Motherhood and pregnancy concerns of Saudi females with multiple sclerosis in Riyadh city: A quantitative analysis.利雅得市患有多发性硬化症的沙特女性的母亲身份及怀孕相关问题:一项定量分析
Neurosciences (Riyadh). 2025 Apr;30(2):150-156. doi: 10.17712/nsj.2025.2.20230122.
8
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registry.利用芬兰多发性硬化症登记处评估患者感知的疲劳情况。
Mult Scler J Exp Transl Clin. 2025 Mar 18;11(1):20552173251325098. doi: 10.1177/20552173251325098. eCollection 2025 Jan-Mar.
9
Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies.多发性硬化症及疾病修正治疗影响的患者体验
Clinicoecon Outcomes Res. 2025 Mar 15;17:199-215. doi: 10.2147/CEOR.S489929. eCollection 2025.
10
Identifying key determinants of work-related difficulties in multiple sclerosis: integrating clinical measures and socio-occupational factors.确定多发性硬化症中与工作相关困难的关键决定因素:整合临床指标和社会职业因素。
Neurol Sci. 2025 Jun;46(6):2747-2757. doi: 10.1007/s10072-025-08058-1. Epub 2025 Feb 26.
寡霉素诱导的多发性硬化模型中 H-MRS 代谢物的变化:先前心理应激的影响。
J Mol Neurosci. 2021 Apr;71(4):804-809. doi: 10.1007/s12031-020-01702-9. Epub 2020 Sep 11.
4
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).利用真实世界数据为决策提供信息:多发性硬化症合作伙伴推动技术与健康解决方案(MS PATHS)。
Front Neurol. 2020 Aug 7;11:632. doi: 10.3389/fneur.2020.00632. eCollection 2020.
5
Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosis.光学相干断层扫描:一种在诊断多发性硬化症时识别亚临床视神经病变的有用工具。
Neurology. 2020 Aug 11;95(6):239-240. doi: 10.1212/WNL.0000000000009840. Epub 2020 Jul 28.
6
A validation study for remote testing of cognitive function in multiple sclerosis.多发性硬化症认知功能远程测试的验证研究。
Mult Scler. 2021 Apr;27(5):795-798. doi: 10.1177/1352458520937385. Epub 2020 Jul 14.
7
Occupational therapy interventions for multiple sclerosis: A scoping review.职业治疗对多发性硬化症的干预:范围综述。
Scand J Occup Ther. 2021 Jul;28(5):399-414. doi: 10.1080/11038128.2020.1786160. Epub 2020 Jul 9.
8
Technology-enabled assessments to enhance multiple sclerosis clinical care and research.借助技术的评估以改善多发性硬化症的临床护理与研究。
Neurol Clin Pract. 2020 Jun;10(3):222-231. doi: 10.1212/CPJ.0000000000000710.
9
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.合并症与 MS 的疾病活动有关:来自 CombiRx 试验的结果。
Neurology. 2020 Aug 4;95(5):e446-e456. doi: 10.1212/WNL.0000000000010024. Epub 2020 Jun 17.
10
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options.多发性硬化症中的脑萎缩:机制、临床相关性及治疗选择。
Auto Immun Highlights. 2019 Aug 10;10(1):7. doi: 10.1186/s13317-019-0117-5. eCollection 2019 Dec.